SleepWhale Extra Strength Drops for deeper sleep and daytime resilience
Evaluating SleepWhale Drops for Rest & Resilience
NA · Efforia, Inc · NCT07298161
This 30-day test will try whether nightly use of SleepWhale Natural Sleep Drops (a non-melatonin adaptogen and botanical formula) helps adults with sleep trouble sleep more deeply and feel better during the day.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Sex | All |
| Sponsor | Efforia, Inc (industry) |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT07298161 on ClinicalTrials.gov |
What this trial studies
This decentralized, 30-day interventional study asks participants to take SleepWhale Natural Sleep Drops nightly and complete weekly check-ins using validated self-report sleep and daytime-function questionnaires. The product is an extra-strength, non‑melatonin blend of adaptogens and botanicals intended to support sleep depth and daytime resilience without causing grogginess or dependence. The trial emphasizes subjective experience over wearable-derived metrics, collecting self-reported outcomes on sleep quality, sleep disruptions, daytime performance, and overall resilience. Data will be used to determine whether regular nightly use of the drops corresponds with meaningful improvements in these patient-reported measures.
Who should consider this trial
Good fit: Adults in the United States who experience sleep disturbances, can read and understand English, are not using sleep medications, and are willing to follow the 30-day protocol and weekly check-ins are ideal candidates.
Not a fit: People who are on sleep medications, pregnant or breastfeeding, have certain medical conditions listed in the exclusions (including mental health, gastrointestinal, skin, headache, dizziness/fatigue issues), or who have severe clinical sleep disorders may not receive benefit from participating.
Why it matters
Potential benefit: If successful, the drops could offer a non‑melatonin, non‑habit forming option that helps people sleep better and feel more alert and resilient during the day.
How similar studies have performed: Some small trials of individual botanicals and adaptogens have shown mixed or modest effects on sleep, but high-quality, large-scale evidence for combined non‑melatonin formulations remains limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Can read and understand English. * US resident. * Willing and able to follow the requirements of the protocol. Exclusion Criteria: * Individuals with Allergies to supplement ingredients * Individuals on sleep Medication * Individuals with Gastrointestinal Issues * Individuals with Skin Conditions * Individuals Prone to Headaches * Individuals with Mental Health Conditions * Pregnant or Breastfeeding Individuals * Athletes and Competitive Participants * Individuals with Dependency Issues * Individuals with Dizziness or Fatigue Issues
Where this trial is running
New York, New York
- Efforia — New York, New York, United States (RECRUITING)
Study contacts
- Study coordinator: Matthew Amsden
- Email: help@efforia.com
- Phone: 646-679-2479
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Sleep